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Introduction
The establishment of peripheral innervation during development 
requires axonal outgrowth to target regions and subsequent re-
finement of connectivity through the removal of exuberant neuro-
nal processes and the elimination of excess neurons via apoptosis 
(Oppenheim,  1991;  Luo  and  O’Leary,  2005).  Developmental 
apoptosis has been extensively studied in sympathetic and dorsal 
root ganglion (DRG) neurons that depend on NGF for their sur-
vival (Levi-Montalcini and Booker, 1960; Crowley et al., 1994). 
In these neurons, loss of NGF signaling results in rapid degenera-
tion (Gorin and Johnson, 1979). Regulators of the intrinsic apop-
tosis pathway including Bcl-2–associated X (BAX) protein and 
Bcl-2 have been implicated in this process (Garcia et al., 1992), 
and mice lacking a functional BAX gene lose significantly fewer 
neurons  during  development  (Deckwerth  et  al.,  1996;  White   
et al., 1998). A c-Jun–dependent transcriptional program is also   
required for apoptosis to proceed, which is initiated after c-Jun 
phosphorylation by the JNK family of MAPKs (Ham et al., 1995; 
Whitfield et al., 2001; Palmada et al., 2002; Besirli et al., 2005). 
This parallels what has been observed after neuronal injury, in 
which phosphorylation of c-Jun and other downstream targets by 
JNK is necessary for neuronal cell death (Bogoyevitch, 2006).
The pathways that underlie the selective degeneration of 
neuronal processes in development and disease are less well   
defined, though a growing body of literature suggests that this 
degeneration is an active process that can be separated from 
neuronal apoptosis. This idea is supported by data demonstrat-
ing that expression of Wld
s, a gene fusion between UFD2/E4 and   
NMAT (nicotinamide nucleotide adenylyltransferase), is able to 
strongly protect axons but not cell bodies from degeneration 
(Mack et al., 2001). Recently, components of the intrinsic path-
ways that regulate axonal degeneration have also been identi-
fied. JNK signaling as well as the ubiquitin proteasome system 
and apoptotic caspases are essential for degeneration in certain 
experimental paradigms, though some model system–dependent 
differences have been observed (Watts et al., 2003; Miller et al., 
2009; Nikolaev et al., 2009; Vohra et al., 2010).
The JNK pathway is required for both neuronal apoptosis 
and axon degeneration but also functions to regulate neuronal 
T
he c-Jun N-terminal kinase (JNK) signaling pathway 
is  essential  for  neuronal  degeneration  in  multiple 
contexts but also regulates neuronal homeostasis. It 
remains unclear how neurons are able to dissociate pro-
apoptotic JNK signaling from physiological JNK activity. 
In this paper, we show that the mixed lineage kinase dual 
leucine zipper kinase (DLK) selectively regulates the JNK-
based stress response pathway to mediate axon degener-
ation and neuronal apoptosis without influencing other 
aspects of JNK signaling. This specificity is dependent on 
interaction of DLK with the scaffolding protein JIP3 to form 
a specialized JNK signaling complex. Local activation of 
DLK-based signaling in the axon results in phosphoryl-
ation of c-Jun and apoptosis after redistribution of JNK to 
the cell body. In contrast, regulation of axon degeneration 
by DLK is c-Jun independent and mediated by distinct JNK 
substrates. DLK-null mice displayed reduced apoptosis 
in multiple neuronal populations during development, 
demonstrating that prodegenerative DLK signaling is re-
quired in vivo.
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excision of exons 2–5, which resulted in no expression of DLK 
protein in the embryonic nervous system (Fig. S1). In the pres-
ence of NGF, DRG neurons from DLK
/ mice in culture 
appeared morphologically normal and displayed comparable 
growth with neurons from wild-type (wt) littermates, indicating 
no major defects in axon outgrowth in this neuronal population 
(Fig. S2). To ascertain whether DLK regulates neuronal apopto-
sis, we cultured DRG neurons in the presence of NGF to elicit 
growth and then withdrew NGF from the culture media to in-
duce  neuronal  degeneration.  Levels  of  apoptosis  after  NGF 
withdrawal were measured by counting the number of neuronal 
cell bodies staining positive with an antibody against the acti-
vated form of caspase 3, which is elevated during apoptosis in 
this cell population. Interestingly, the presence of activated cas-
pase 3 in neuronal cell bodies was strikingly reduced in DLK
/ 
neurons as compared with controls, indicative of a significant 
protection of DLK
/ neurons from apoptosis induced by NGF 
withdrawal (Fig. 1, A–D).
NGF deprivation has also been shown to induce axonal 
degeneration independent of cell death in NGF-dependent cell 
populations  (Campenot,  1977);  therefore,  we  next  explored 
whether DLK is also required for axon degeneration using DRG 
explant cultures. Interestingly, whereas axons grown from wt 
DRG explants completely degenerated by 18 h, DLK-null neu-
rons displayed minimal degeneration at this time point (Fig. 1, 
E–H). The axonal protection observed in explant cultures could 
be a secondary result of the antiapoptotic effects of DLK re-
moval, so we next examined whether DLK affects local axon 
degeneration using compartmentalized chambers that separate 
axons from cell bodies. When NGF is removed only from the 
axonal compartment in this experimental setup, degeneration of 
axons proceeds on a similar timeline to that observed in ex-
plants, but no significant apoptosis occurs during this time pe-
riod (Campenot, 1977; Mok et al., 2009). Similar to what was 
observed in explants, DLK
/ axons displayed significantly re-
duced degeneration after NGF deprivation as compared with 
axons from wt littermates (Fig. 1, I–L). These data argue that 
DLK is critical for both axon degeneration and cell death in re-
sponse to growth factor deprivation. Importantly, loss of DLK 
is also able to protect against local axon degeneration, arguing 
that it has an essential role in this process even in conditions in 
which neuronal apoptosis does not occur.
DLK activates a JNK-mediated stress 
response pathway
To identify pathways modulated by DLK in the context of devel-
opmental degeneration in mouse, the activation of MAPK path-
ways was measured in cultured DRG neurons after 3 h of NGF 
deprivation. This early time point is before significant degenera-
tion but is sufficient to cause a fourfold reduction in the levels   
of phosphorylated extracellular signal-regulated kinase (ERK;   
p-ERK) resulting from the loss of NGF/TrkA-based survival 
signaling. Levels of p-ERK were similar in wt and DLK
/ neu-
rons, arguing that the removal of DLK does not protect neurons 
via maintaining ERK activity in the absence of NGF (Fig. 2,   
A and B). Levels of phosphorylated JNK (p-JNK) and phos-
phorylated P38- were unchanged at this time point, though   
growth and homeostasis (Chang et al., 2003; Björkblom et al., 
2005). Neurons contain high levels of activated JNK even in the 
absence of stress but have the ability to discriminate this basal 
activity from proapoptotic JNK signaling (Coffey et al., 2000). 
Studies using JNK-null mice have demonstrated that each of   
the three mammalian JNK genes has specific functions, which ex-
plains at least in part how this selectivity is achieved. For in-
stance, mice lacking JNK2 and/or JNK3 are protected from 
stress-induced  neuronal  apoptosis  and  display  reduced  phos-
phorylation of stress-specific downstream targets such as c-Jun, 
whereas JNK1-null mice show no protection (Chang et al., 2003; 
Hunot et al., 2004; Yang et al., 1997). Additional selectivity is 
likely to be mediated via interaction of JNKs with JNK-interacting 
proteins (JIPs), which are thought to facilitate formation sig-
naling  complexes  comprised  of  JNKs  and  upstream  kinases 
(Whitmarsh, 2006). It has been hypothesized that specific combi-
nations of JNK, JIP, and upstream kinases can lead to highly spe-
cific JNK signaling complexes with defined outputs (Waetzig and 
Herdegen, 2005), but few such complexes have been identified.
Experiments using the pan-mixed lineage kinase (MLK) 
inhibitor CEP-1347 have suggested that this family of kinases   
is  a  major  upstream  regulator  of  JNK  activation  in  neurons   
(Maroney et al., 1998), yet the specific MLKs that control neuro-
nal degeneration are not well defined. Recently, the MLK dual 
leucine zipper kinase (DLK) has been shown to play a role in 
neuronal injury–induced axonal degeneration, a function that is 
likely JNK mediated (Miller et al., 2009). In other contexts, how-
ever, DLK does not mediate degeneration and is instead required 
for axonal regeneration after injury (Hammarlund et al., 2009; 
Xiong et al., 2010). During development, DLK is a component of 
a pathway that regulates axon outgrowth and synapse formation 
via regulation of JNK and/or P38 MAPKs (Nakata et al., 2005; 
Collins et al., 2006; Hirai et al., 2006; Lewcock et al., 2007), and 
reduced DLK expression either directly or indirectly leads to in-
creased numbers of spinal motor neurons (Itoh et al., 2011).
In this study, we sought to understand the mechanisms of 
DLK-based signaling in the context of nervous system develop-
ment. Using an in vitro NGF withdrawal paradigm that mimics 
the competition for trophic factors encountered by peripherally 
projecting sensory neurons in vivo, we discovered that DLK is 
required for both axonal degeneration and neuronal apoptosis. 
DLK-mediated degeneration is based on specific regulation of 
stress-induced JNK activity in axons that is achieved via inter-
action of DLK with the scaffolding protein JIP3. These results are 
further supported by the observation that developmental apopto-
sis is significantly reduced in multiple neuronal populations 
in vivo. Collectively, this suggests that DLK-based regulation of 
the JNK signaling pathway is essential for the neuronal apopto-
sis and axon degeneration that occur during development.
Results
DLK is required for neuronal apoptosis and 
axon degeneration in DRG neurons
DLK is specifically expressed in postmitotic neurons during   
development, including neurons of the DRG and spinal cord   
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(Figs. 2 [C and D] and S3). Interestingly, NGF deprivation re-
sulted in a redistribution of p-JNK from axons to cell bodies 
over a period of 4 h, which did not occur in DLK
/ neurons 
(Figs. 2 [E and F] and S3). Staining of cultures with an antibody 
directed to Tuj1 confirmed that the lack of p-JNK labeling in 
axons was not a result of the axons degenerating but rather a 
specific relocalization of p-JNK to the cell body (Fig. 2, G and H). 
The timing of p-JNK relocalization strongly correlated with the 
number of neurons that stained positive for p-c-Jun (Fig. 2, I–K), 
consistent with the hypothesis that nuclear localization of p-JNK 
is required for c-Jun phosphorylation and neuronal apoptosis 
(Björkblom et al., 2008).
To define the functional role of the increased JNK activity 
observed in DRG neurons as a consequence of NGF withdrawal, 
we tested the effect of JNK inhibitors on NGF withdrawal– 
induced degeneration. Pharmacological inhibition of JNK ac-
tivity was sufficient to significantly reduce levels of caspase 3 
activation observed in dissociated DRG cultures (Fig. 3, A–C) 
and rescue axons from degeneration (Fig. 3, D–F) induced by 
NGF deprivation. These protective effects were similar to those 
examination of p-JNK 1 h after NGF withdrawal revealed that 
levels were increased roughly threefold over controls at this 
early time point. This increase was largely absent in DLK
/ 
neurons, where levels increased only 1.4 fold after NGF depriva-
tion. A more thorough time course revealed that, after the tran-
sient increase in p-JNK at 1 h, levels remained similar to control 
through 9 h in wt neurons but were not elevated in DLK
/ neu-
rons at any time point examined (Fig. S3). Phosphorylated c-Jun 
(p-c-Jun) levels were also significantly elevated beginning 3 h 
after NGF deprivation in wt neurons and extending until the onset 
of degeneration, an increase that was absent in DLK
/ neurons 
(Figs. 2 [A and B] and S3). These data suggest that the with-
drawal of NGF induces JNK-based stress response pathways in 
DRG neurons and that this activation is DLK dependent.
To better understand the mechanism of JNK activation   
induced by NGF withdrawal, we next examined p-JNK localiza-
tion by immunostaining to determine the subcellular distribu-
tion of p-JNK protein. Under normal culture conditions, DRG 
neurons showed punctate p-JNK staining throughout the cell 
body and neuronal processes in both wt and DLK
/ neurons 
Figure 1.  Apoptosis and axon degeneration are significantly reduced in DLK
/ neurons. (A–C) Cultured DRG neurons from E13.5 embryos stained with 
antibodies for activated caspase 3 (green) and Tuj1 (red). Neurons grow robustly in the presence of NGF (A) and display negligible activated caspase 3 
staining. Caspase 3 is activated in many neurons after 8 h of NGF withdrawal in wt (DLK
+/+) neurons (B) but is reduced in DLK
/ neurons (C). Bar, 50 µm. 
(D) Quantification of cultures shown in A–C reveals significantly less activation of caspase 3 in DLK
/ neurons (wt = 79 ± 17% and DLK
/ = 5 ± 4.5% 
of neurons; n = 3; ***, P < 0.001). (E–G) Tuj1 staining of DRG explants from wt and DLK
/ embryos in the presence or absence of NGF. NGF results in 
robust axon outgrowth from explants (E). Withdrawal of NGF from explant cultures results in the degeneration of axons in a period of 18 h in wt explants 
(F) but not in DLK
/ explants (G). Bar, 100 µm. (H) Quantification of cultures shown in F and G using a scoring system designed to measure the amount 
of axon degeneration (0 = no degeneration, and 5 = complete degeneration) reveals significantly less degeneration in DLK
/ axons (wt = 4.7 ± 0.1 and 
DLK
/ = 0.8 ± 0.2; n = 5; ***, P < 0.001). (I–K) Tuj1 staining of DRG axons from E13.5 embryos from wt and DLK
/ embryos grown in compartmental-
ized (Comp.) chambers that separate distal axons from cell bodies. NGF elicits robust growth (I), and removal of NGF from the axonal compartment only 
results in rapid local degeneration of wt axons (J) but not DLK
/ axons (K) in 28 h. Bar, 50 µm. (L) Quantification of compartmentalized chamber cultures 
shown in J and K using the aforementioned scoring system reveals reduced axon degeneration in DLK
/ (wt = 4.25 ± 0.1 and DLK
/ = 1.3 ± 0.1; n = 2; 
**, P < 0.01). Error bars represent SEM.JCB • VOLUME 194 • NUMBER 5 • 2011   754
Figure 2.  DLK is required for activation of stress-induced JNK signaling in neurons but does not affect basal JNK activity. (A and B) Phosphorylation levels of 
ERK, JNK, and c-Jun in E13.5 DRG neuron cultures from wt (DLK
+/+) and DLK
/ embryos in the presence or absence of NGF by Western blotting (A). Quan-
tification of A reveals that levels of p-ERK are reduced in both DLK
/ and wt neurons 3 h after NGF withdrawal (wt = 26.2 ± 19% and DLK
/ = 19.1 ±   
13% of NGF control; n = 4; *, P < 0.05), whereas no change in p-JNK is observed at this time point. At 1 h, p-JNK levels are increased in wt neurons but 
not DLK
/ neurons after NGF withdrawal (wt = 289 ± 100% and DLK
/ = 143 ± 16% of NGF control; n = 4; P < 0.05). wt neurons displayed a large 
increase in p-c-Jun 3 h after NGF withdrawal, which is significantly reduced in DLK
/ neurons (wt = 717 ± 146% and DLK
/ = 201 ± 58% of NGF 
control; n = 4; **, P < 0.01; B). Molecular mass is indicated in kilodaltons. (C–F) Cultured DRG neurons from E13.5 embryos stained with antibodies for 
activated p-JNK and NeuN. p-JNK is largely relocalized from the axon (white arrow) to the nucleus (open arrow) after 4 h of NGF withdrawal in wt neurons 
but not in DLK
/ neurons. (G and H) DRG neurons stained with Tuj1 show that loss of p-JNK in axons is not a result of axonal degeneration at this time 
point. (I) Quantification of cultures shown in J and K reveals significantly less p-c-Jun staining in DLK
/ neurons (wt = 93 ± 11.5% and DLK
/ = 9 ± 9% of 
neurons; n = 2; **, P < 0.01). (J and K) DRG neurons stained with activated p-c-Jun and NeuN. In wt cultures, the majority of neurons are p-c-Jun positive 
after 4 h of NGF withdrawal, whereas in DLK
/ cultures, only a few neurons show dim staining for p-c-Jun. Error bars represent SEM. Bars,10 µm.755 DLK required for JNK-dependent neuronal degeneration • Sengupta Ghosh et al.
protection despite efficient knockdown of JIP1 protein (Figs. 4 
[A–G] and S4).
To determine whether JIP3 and DLK can form a signaling 
complex, we tested whether these two proteins interact when 
coexpressed  in  HEK-293  cells.  Immunoprecipitation  (IP)  of 
Flag-tagged  DLK  was  able  to  pull  down  coexpressed  Myc-
tagged JIP3 but not a GFP control (Fig. 4 H), indicating that 
these proteins can interact. To investigate whether this JIP3–
DLK complex was functionally relevant, we next assessed the 
ability of JIP3 to enhance the DLK-dependent activation of 
JNK and c-Jun. Transfection of DLK into HEK-293 cells re-
sulted in increased phosphorylation of JNK and c-Jun, even in 
the absence of any extrinsic stress on these cells (Fig. 4 I). This 
phosphorylation did not occur after transfection of a kinase-
dead DLK construct, arguing that it is a specific signaling event 
(unpublished data). Transfection of JIP3 alone did not result in 
significant phosphorylation of JNK, but when JIP3 was cotrans-
fected with DLK, it resulted in notably higher levels of p-JNK 
and p-c-Jun than DLK alone (Fig. 4 I). This demonstrates that 
DLK activity is sufficient to stimulate the phosphorylation of 
JNK, and JIP3 enhances this activation.
To  determine  whether  a  DLK–JIP3  complex  regulates 
stress-induced JNK activity in neurons, we next examined 
whether the endogenous DLK and JIP3 genes interact as was 
observed after overexpression in HEK-293 cells. Sufficient 
protein for IP studies could not be obtained from DRG neurons, 
observed in DLK
/ neurons (Fig. 1, A–H). As small molecule 
inhibitors can often inhibit multiple kinases in addition to their 
desired target, this experiment was repeated with two additional 
structurally distinct JNK inhibitors, which yielded similar re-
sults (SP600125 and JNK VIII; unpublished data). These data 
support a mechanism in which DLK is required for activation of 
the JNK–c-Jun stress response pathway that occurs in neurons 
as a result of NGF deprivation, and this JNK activity results in 
neuronal apoptosis and degeneration of axons.
Selective activation of JNK by DLK 
requires JIP3
The observation that DLK
/ neurons retain normal localiza-
tion and levels of p-JNK when cultured in the presence of NGF, 
yet display deficiencies in p-JNK relocalization and attenuated 
phosphorylation of c-Jun in NGF deprivation paradigms, sug-
gested that DLK is able to selectively modulate the prodegener-
ative aspects of JNK signaling. We hypothesized that this may 
be achieved through the interaction of DLK with a specific JIP 
to form a signaling complex that would allow for restricted 
JNK activation. To test this possibility, we examined whether 
siRNA-based knockdown of individual JIPs was able to pheno-
copy the protective effects observed in DLK
/ neurons. Inter-
estingly,  siRNA-based  knockdown  of  JIP3  provided  similar 
levels  of  protection  to  those  observed  after  knockdown  or 
knockout of DLK, whereas JIP1 siRNAs provided negligible 
Figure 3.  Inhibition of JNK activity protects DRG neurons from degeneration. (A and B) DRG neurons from E13.5 embryos stained with antibodies for 
activated caspase 3 (Casp3) and Tuj1 after 8 h of NGF withdrawal. Caspase 3 is activated in many untreated neurons (A), but fewer neurons treated with 
the JNK inhibitor (JNKi) AS601245 displayed caspase activation (B). (C) Quantification of cultures shown in A and B reveals significantly less activation of 
caspase 3 in neurons treated with JNK inhibitor AS601245 (untreated = 89 ± 4.1% and JNK inhibitor = 12 ± 4.5% of neurons; n = 3; ***, P < 0.001). 
(D and E) DRG neurons from wt E13.5 embryos after 18 h of NGF withdrawal and stained with Tuj1. Untreated neurons were completely degenerated (D), 
whereas neurons treated with the JNK inhibitor AS601245 did not show significant degeneration (E). Bar, 50 µm. (F) Quantification of the total neurite 
length in the culture shown in D and E reveals significant inhibition of degeneration in the presence of JNK inhibitor AS601245 (untreated = 2.9 ± 0.9% 
and JNK inhibitor = 90 ± 28% of NGF control [Cntl; w/NGF]; n = 3; ***, P < 0.001). Error bars represent SEM.JCB • VOLUME 194 • NUMBER 5 • 2011   756
electroporated with a JIP3 siRNA after 3 h of NGF depriva-
tion, and the modest increase in p-JNK at 1 h was not observed 
after JIP3 knockdown (Fig. 4, K and L). siRNA-based knock-
down of JIP3 also inhibited relocalization of p-JNK in dissoci-
ated DRG cultures (unpublished data). Although these data 
cannot distinguish between a direct JIP3–DLK interaction and 
one that requires additional binding partners, it strongly sug-
gests that DLK and JIP3 are components of a signaling complex 
that is required for JNK and c-Jun phosphorylation induced by 
NGF withdrawal.
so whole-brain lysate from neonatal mice (postnatal day 1) was 
used as a substitute. Consistent with our previous observations, 
IP with an anti-DLK antibody was also able to pull down JIP3 
protein, which was not observed in an IgG control (Fig. 4 J). 
The functional relevance of this interaction was then examined 
by measuring the phosphorylation of JNK, c-Jun, and ERK in 
DRGs after siRNA knockdown of JIP3 in the presence or ab-
sence of NGF. The results observed were nearly identical to 
those observed with DLK
/ neurons, i.e., the increase in levels 
of p-c-Jun seen in control cultures was not observed in neurons 
Figure 4.  JIP3 is required for neuronal degeneration and forms a complex with DLK, which regulates neuronal JNK activity. (A–F) Tuj1 staining of DRG 
neurons from E13.5 embryos electroporated with various siRNAs and cultured in the presence of NGF or after 18 h of NGF withdrawal. An siRNA against 
JIP1 (A and B) did not protect neurons from degeneration, whereas siRNAs against JIP3 (C and D) or DLK (E and F) provided significant protection from 
degeneration. Bar, 50 µm. (G) Quantification of the total neurite length in the cultures shown in A–F reveals that siRNAs directed against either JIP3 or   
DLK provide significant protection against NGF withdrawal–induced degeneration (control [CNTL] = 2.6 ± 1.9%, DLK = 61 ± 12%, JIP1 = 1.3 ± 1.2%, 
and JIP3 = 55 ± 13%; n > 3; ***, P < 0.001) (H) A Western blot for Flag-DLK and Myc-JIP3 after IP of Flag-DLK from cotransfected HEK-293 cells. Myc-JIP3 
but not GFP is pulled down with Flag-DLK when the two proteins are coexpressed. IB, immunoblot. (I) A Western blot for p-JNK and p-c-Jun after trans-
fection of DLK and/or JIP3 in HEK-293 cells. Transfection of DLK in the absence of stress results in increases in p-JNK and p-c-Jun. Transfection of JIP3 
alone does not activate p-JNK or p-c-Jun, yet cotransfection of DLK and JIP3 results in more JNK and c-Jun phosphorylation than transfection of DLK alone.   
(J) A Western blot for DLK and JIP3 after IP from neonatal mouse brain using an anti-DLK antibody. Both proteins are pulled down by the anti-DLK antibody 
but not in control experiments using no antibody (Beads Cntl) or an IgG control (IgG Cntl). (K and L) Phosphorylation levels of ERK, JNK, and c-Jun in E13.5 
DRG neuron cultures electroporated with either a control siRNA or a JIP3 siRNA by Western blotting (K). Quantification of K reveals that levels of p-ERK 
are reduced in both control and JIP3-treated neurons 3 h after NGF withdrawal (control = 39 ± 10%, JIP3 = 44 ± 9.5%; n = 3; *, P < 0.05), whereas no 
change in p-JNK is observed at this time point. At 1 h, p-JNK levels are increased in control neurons but not JIP3-treated neurons after NGF withdrawal 
(control = 390 ± 4.2%, JIP3 = 119 ± 18%; n = 3; **, P < 0.01). Control neurons displayed an even larger increase in p-c-Jun 3 h after NGF withdrawal, 
which is significantly reduced in JIP3-treated neurons (control = 629 ± 118% and JIP3 = 141 ± 49%; n = 3; ***, P < 0.001; L). The control is an siRNA 
directed against luciferase. Molecular mass is indicated in kilodaltons. Error bars represent SEM.757 DLK required for JNK-dependent neuronal degeneration • Sengupta Ghosh et al.
a significant reduction in the number of p-c-Jun–positive cells 
was observed (Fig. 5, D–H), arguing that the DLK–JIP3 signal-
ing complex is essential for c-Jun phosphorylation. Experiments 
using  siRNA-based  knockdown  were  unable  distinguish  be-
tween DLK–JIP3 acting in the distal axon or in the central com-
partment in response to a distinct peripherally derived signal.   
To address this, a complementary experiment was performed in 
which NGF was removed from all compartments, and JNK in-
hibitors were added to the distal axons only (Fig. 5 I). JNK   
inhibitors used as specific inhibitors of DLK were not available, 
and our data suggest that DLK-induced degeneration is me-
diated largely by JNK (Fig. 3). Removal of NGF from all 
compartments  of  the  chamber  results  in  neuronal  apoptosis 
equivalent to that seen in dissociated cultures (Mok et al., 2009) 
and allows assessment of whether inhibition of DLK–JNK in 
the distal axon is sufficient to prevent cell death. We again   
DLK activation in distal axons initiates a 
retrograde stress response
Our previous work demonstrated that a significant portion of 
DLK protein was localized to the growth cone in projecting   
axons (Lewcock et al., 2007). This raises the possibility that 
regulation of neuronal apoptosis by DLK originates in the pe-
riphery  and  is  retrogradely  transported  back  to  the  nucleus.   
To test this hypothesis, we again used DRG neurons grown in 
compartmentalized culture chambers to separate axons from 
cell bodies (Fig. 5 A). In this setup, removal of NGF selectively 
from distal axons does not result in rapid neuronal apoptosis but 
is sufficient to induce phosphorylation of c-Jun in the nucleus 
within 6 h, a similar timeline to what is observed in dissociated 
cultures (Fig. 5, B and C; Mok et al., 2009). Interestingly, when 
this experiment was conducted in neurons electroporated with 
siRNAs directed against either DLK or JIP3 before plating,   
Figure 5.  DLK, JIP3, and JNK are components of a peripherally derived stress signal that regulates c-Jun phosphorylation. (A) A schematic of an experi-
ment using compartmentalized culture chambers shown in B–G in which NGF is removed from distal axons only, and levels of p-c-Jun are visualized in the 
central chamber containing cell bodies. (B–G) A central compartment of culture chamber containing DRG neurons stained with p-c-Jun (green in B, D, and F)   
or p-c-Jun merged with DAPI (blue) and Tuj1 (red) after 6 h of NGF withdrawal from distal axons (C, E, and G). Neurons electroporated with a control (Cntrl) 
siRNA show many p-c-Jun–labeled neurons (B and C), whereas neurons electroporated with siRNAs directed to DLK (D and E) or JIP3 (F and G) have fewer 
p-c-Jun–positive nuclei. Bar, 50 µm. (H) Quantification of the percentage of p-c-Jun–positive cells shown in B–G after NGF withdrawal from distal compart-
ments (control [Cntl] = 51.0 ± 10%, JIP3 = 7.7 ± 2.4%, and DLK = 4.3 ± 1.7%; **, P < 0.01). (I) A schematic of an experiment shown in K–M in which   
NGF is removed from all compartments, and the JNK inhibitor (JNKi) AS601245 is added only to the distal axon compartments or all compartments.   
(J) Quantification of p-c-Jun–labeled cells after NGF withdrawal ± JNK inhibitors in different compartments (untreated = 70.6 ± 17%, axons = 7.8 ± 2%, 
and all = 5.2 ± 1.4%; **, P < 0.01). (H and J) n = 2. Error bars represent SEM. (K–M) Staining of DRG cell bodies for p-c-Jun (green) and DAPI (blue) 
6 h after NGF withdrawal (K). The addition of the JNK inhibitor to the distal axon compartment alone results in minimal c-Jun phosphorylation after NGF 
withdrawal from all compartments (L). The addition of the JNK inhibitor to all compartments also inhibits c-Jun activation (M). Bar, 50 µm.JCB • VOLUME 194 • NUMBER 5 • 2011   758
JNK but not c-Jun is required for  
axonal degeneration
Next, we addressed whether regulation of axon degeneration by 
DLK is also c-Jun dependent. To do this, we measured levels 
of axon degeneration in c-Jun conditional–null mice crossed 
to a Nestin-Cre (Behrens et al., 2002), which eliminates c-Jun 
expression in nearly all DRG neurons by E13.5 (embryonic 
day 13.5; abbreviated c-Jun
lox/lox; unpublished data). NGF was 
withdrawn from explants for 14, 16, or 18 h to assess the rate 
of axon degeneration in each genotype. Surprisingly, axons 
from c-Jun
lox/lox explants degenerated at similar rates to axons 
examined p-c-Jun levels as a readout, as previous studies have 
shown that it is an essential step toward neuronal apoptosis   
under conditions of global NGF deprivation (Ham et al., 1995; 
Whitfield et al., 2001; Palmada et al., 2002). Interestingly,   
the addition of JNK inhibitors to distal axons alone was able to 
significantly reduce numbers of p-c-Jun–positive cells in the 
central compartment to levels similar to those seen when JNK 
inhibitors  were  added  to  all  compartments  (Fig.  5,  J–M). 
These observations suggest that DLK–JNK activity in distal 
axons is necessary though not sufficient for NGF withdrawal– 
induced apoptosis.
Figure 6.  DLK–JNK-dependent regulation of axon degeneration is independent of c-Jun. (A–F) Tuj1 staining of axons from wt (c-Jun
lox/lox and Cre nega-
tive) and c-Jun
lox/lox DRG explants after 14 (A and B), 16 (C and D), or 18 (E and F) h of NGF withdrawal. (G and H) Tuj1 staining of axons from wt and 
c-Jun
lox/lox DRG explants treated with JNK inhibitor AS601245 after 18 h of NGF withdrawal. (A–H) Bar, 25 µm. (I) Quantification of explants shown in 
A–H reveals that degeneration of c-Jun
lox/lox axons is comparable with wt controls, but the addition of a JNK inhibitor (JNKi) provides significant protection 
in both genotypes (18-hr axon degeneration score: wt = 3.6 ± 0.9, c-Jun
lox/lox = 3.5 ± 0.4, wt + JNKi = 0 ± 0, and c-Jun
lox/lox + JNKi = 0.3 ± 0.1; n = 5; 
***, P < 0.001). (J) Quantification of caspase 3 staining shown in K and L reveals significantly less active caspase 3–positive c-Jun
lox/lox neurons compared 
with wt littermates (wt = 73 ± 5.3% and c-Jun
lox/lox = 15 ± 2.2% of neurons; n = 3; **, P < 0.01). (K and L) DRG neurons from E13.5 embryos stained with 
antibodies for activated caspase 3 (Active Casp2) and Tuj1 after 8 h of NGF withdrawal. Caspase 3 is activated in many wt neurons after 8 h of NGF 
withdrawal (K) but in fewer c-Jun
lox/lox neurons (L). Bar, 50 µm. (M–O) DRG explants from wt, DLK
/, and c-Jun
lox/lox stained for activated caspase 9 and 
Tuj1. Caspase 9 is activated in many axons after 8 h of NGF withdrawal in wt and c-Jun
lox/lox neurons (M and O), but no activation is observed in DLK
/ 
neurons (N). Bar, 100 µm. (P) Quantification of active caspase 9 in DRG explants from DLK
/, c-Jun
lox/lox, and controls shown in M–O reveals significantly 
less activation of caspase 9 in DLK
/ axons as compared with wt and c-Jun
lox/lox DRG axons (c-Jun
lox/lox = 3.2 ± 0.4 and DLK
/ = 0.2 ± 0.3; n = 3;   
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region (Fig. 7, A–C). When the number of pan-Trk–stained 
neurons was normalized to the total DRG area, a 1.5-fold in-
crease in neuronal number/DRG area was still observed in 
DLK
/ embryos, indicative of more neurons being packed 
into individual DRGs (Fig. 7 D). The phenotype of DLK
/ 
neurons we observed in culture suggested that the increase in 
Trk-positive cell number observed at later stages was likely a 
result  of  reduced  developmental  apoptosis  in  DLK
/  em-
bryos. To test this hypothesis, E15.5 embryos were stained for 
the activated form of caspase 3, which revealed a 1.7-fold de-
crease in the amount of cells per area undergoing apoptosis in 
DLK
/ DRGs as compared with wt littermate controls (Fig. 7, 
E–G). We were unable to identify in vivo axon degeneration 
phenotypes in DRG neurons as a result of two main limita-
tions. First, no measurable axonal degeneration/pruning events 
in DRG neurons have been identified that occur in the absence 
of a secondary mutation (Schoenmann et al., 2010). Second, it 
would be impossible to discriminate between true axon degen-
eration defects and axonal misprojection as a result of excess 
DRG neurons in DLK
/ mice.
DLK is broadly expressed in the nervous system, so we 
next examined whether reductions in developmental apoptosis 
also occurred in spinal motor neurons, another neuronal popula-
tion in which excess neurons are lost between E13.5 and 17.5 
(White et al., 1996, 1998). To do this, we stained lower thoracic 
spinal cord sections from DLK
/ mice with an antibody to 
HB9, a spinal motor neuron–specific marker (Arber et al., 
1999). Normal numbers of HB9-positive motor neurons were 
present in DLK
/ embryos at E13.5, yet by E15.5, the number 
of motor neurons in DLK
/ embryos was roughly double that 
of wt littermates (186% of control; Fig. 7, H–K and N). This in-
crease in cell number was sustained at E17.5, the latest time 
point examined as a result of neonatal lethality of DLK-null   
animals (180% of control; Fig. 7, L–N). As initial numbers of 
motor neurons were generated in DLK
/ embryos, this phenotype 
is likely a result of reduced developmental apoptosis in motor 
neurons during later stages of development, similar to what was 
observed in DRGs. In addition, our results are comparable with 
changes in the motor neuron cell number observed in animals 
lacking choline acetyltransferase or BAX, both of which also 
display defects in developmental loss of motor neurons at simi-
lar developmental stages (White et al., 1998; Brandon et al., 
2003).  Collectively,  these  data  suggest  that  DLK-dependent 
signaling pathways are essential to developmental apoptosis in 
multiple neuronal types.
Discussion
DLK is required for neuronal degeneration 
during development
In this study, we identify a role for DLK as a critical regulator 
of  neuronal  degeneration  in  multiple  peripherally  projecting 
neurons during development. DLK functions in this context by ac-
tivating JNK-based stress response signaling in a JIP3-dependent 
fashion without affecting basal JNK activity. The phenotypes 
observed in DLK
/ mice suggest that DLK is essential for 
prodegeneration signaling in response to developmental cues in 
from wt or heterozygous littermates (Fig. 6, A–F and I). How-
ever, when JNK inhibitors were added to c-Jun
lox/lox explants 
during  NGF  deprivation,  a  strong  protection  of  axons  was   
observed (Fig. 6, G–I). To confirm that the loss of c-Jun is suf-
ficient to rescue neuronal apoptosis of DRG neurons, we exam-
ined the activation of caspase 3 in neuronal cell bodies after 
the removal of NGF. Consistent with previous studies in sym-
pathetic neurons (Ham et al., 1995; Palmada et al., 2002),   
a significantly reduced number of c-Jun
lox/lox neurons stained 
with an antibody specific for the activated form of caspase 3 
(Fig. 6, K and L). This implies that, although c-Jun is essential 
for  neuronal  apoptosis  after  NGF  withdrawal,  downstream 
targets of JNK activity other than c-Jun regulate axon degen-
eration after NGF deprivation.
Activation of caspases is downstream of JNK–c-Jun ac-
tivity in apoptosis of sympathetic neurons (Whitfield et al., 
2001) and has more recently been demonstrated to be essential 
for  axon  degeneration  in  the  context  of  NGF  withdrawal 
(Nikolaev et al., 2009; Schoenmann et al., 2010). Based on 
these findings, we sought to determine whether caspases were 
activated in DLK
/ axons. To do this, we monitored the ac-
tivity of caspase 9, as this is the primary initiator caspase in 
the  intrinsic  cell  death  pathway  and  downstream  of  BAX, 
which is also required for axon degeneration (Nikolaev et al., 
2009). Using a cleaved caspase 9–specific antibody, activa-
tion of this protease could be observed after 8 h of NGF with-
drawal in axons of wt explant cultures, but no activation was 
observed in axons of DLK
/ explants, indicating that DLK is 
upstream of axonal caspase activity (Fig. 6, M–P). To deter-
mine whether c-Jun is required downstream of DLK for cas-
pase 9 activation, we conducted a similar experiment using 
c-Jun
lox/lox neurons. Consistent with the timeline of degenera-
tion  observed  in  c-Jun
lox/lox  explants,  c-Jun
lox/lox  axons  had 
similar levels of active caspase 9 present in axons as com-
pared with wt control cultures (Fig. 6, M and O), whereas 
treatment of wt cultures with JNK inhibitors yielded similar 
levels of caspase 9 activation to what was seen in DLK
/ 
neurons (not depicted). This suggests that, unlike what has 
been reported in the context of neuronal apoptosis after NGF 
withdrawal, caspase activation and subsequent degeneration 
of axons are not dependent on c-Jun transcriptional activity.
DLK is required for developmental 
apoptosis in vivo
To determine the relevance of DLK for neuronal apoptosis 
and axon degeneration in normal development, we examined 
the phenotype of DLK
/ mice during the period of axon pro-
jection and refinement in DRG neurons (E12.5–17.5). At E12.5,   
a developmental stage before any significant developmental 
apoptosis  in  DRG  neurons  (White  et  al.,  1998),  DLK-null 
mice were grossly indistinguishable from wt littermates and dis-
played normal patterns of motor and sensory axon outgrowth   
in vivo, consistent with our in vitro observations (Fig. S5). How-
ever,  examination  of  E17.5  embryos  revealed  notable  in-
creases in the number of DRG neurons in DLK-null animals, 
with a 1.8-fold increase in the total number of pan-Trk–stained 
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circumvent DLK to initiate degeneration either using a different 
MAPKKK or via a completely distinct pathway. Nevertheless, 
the extent of protection observed in DLK
/ mice in vivo indi-
cates that DLK-dependent degeneration is a major neuronal de-
generation pathway used during development.
Mechanisms of DLK-dependent 
degeneration
Our  data  suggest  that  DLK  regulates  neuronal  degeneration 
largely via modulation of the JNK signaling pathway. In con-
trast to many other cell types, neurons maintain relatively high 
levels of active JNK even in the absence of stress (Coffey et al., 
2000). This high level of p-JNK does not lead to the phosphory-
lation of proapoptotic downstream targets such as c-Jun and has 
been hypothesized to phosphorylate a distinct set of downstream 
targets involved in neuronal growth and function (Coffey et al., 
2000; Waetzig and Herdegen, 2005). Interestingly, the removal 
of DLK does not appear to significantly affect the nonstress 
levels of p-JNK as judged by Western blotting and staining of 
neuronal cultures, and the alterations in p-JNK levels even after 
NGF withdrawal are relatively small compared with the changes 
observed in stress-specific JNK targets such as p-c-Jun (Fig. 2). 
The same is not true when neuronal MAPKKKs are broadly 
both motor and sensory neurons. Previous work has estab-
lished that 50–60% of motor neurons are lost by apoptosis   
during  development  (Oppenheim,  1991);  therefore,  the  near 
doubling of DRG and motor neurons observed in DLK
/ mice 
implies that these embryos lose few neurons during this time 
period. This level of protection is surprising, given the amount 
of cross talk that is often observed within MAPK pathways. 
Multiple MAPKKKs have been shown capable of activating 
JNK via MKK4/MKK7 in various contexts (Xu et al., 2001), 
which leads to the prediction that stress-induced JNK activation 
would still occur in the absence of a single gene within the path-
way. The fact that this does not appear to be the case in DLK
/ 
embryos could be attributable to many factors, including ex-
pression levels within neurons, specific DLK-interacting pro-
teins, or localization of DLK protein to sites within the distal 
axon where stress is first encountered. Additional studies will 
be required to discriminate between these possibilities. DRG 
neurons from DLK
/ embryos do eventually degenerate in our 
in vitro experimental conditions after longer periods of NGF 
withdrawal (>72 h; unpublished data). This is in contrast to 
what was observed in BAX-null neurons, which continue to sur-
vive for prolonged periods in the absence of NGF (Deckwerth   
et al., 1996). This implies that neurons are eventually able to 
Figure 7.  Developmental loss of DRG and motor neurons is reduced in DLK
/ embryos. (A and B) Immunohistochemical staining of lumbar level DRGs 
from E17.5 DLK
/ and wt (DLK
+/+) littermates with a pan-Trk antibody. DLK
/ DRGs (B) appear larger and contain more Trk-positive neurons than wt 
controls (A). The border of the DRG is indicated by the dotted lines. Bar, 25 µm. (C) Quantification of pan-Trk staining of DRGs shown in A and B. Sig-
nificantly more Trk-positive cells per section are present in DRGs of DLK
/ DRGs as compared with wt controls (wt = 155 ± 29 and DLK
/ = 267 ± 31 
cells/section; n = 3; **, P < 0.01). (D) Normalization of Trk-positive cells to DRG area also showed an increase in the number of neurons in DLK
/ DRGs 
as compared with wt (wt = 2.0 ± 0.23 and DLK
/ = 2.98 ± 0.39 cells/DRG area; n = 3; *, P < 0.05). (E and F) Immunohistochemical staining of lumbar 
level DRGs from E15.5 DLK
/ and wt (DLK
+/+) littermates with an antibody specific for active caspase 3. The border of the DRG is indicated by the dotted 
lines. DLK
/ DRGs (F) have less active caspase 3 staining than wt controls (E). Bar, 25 µm. (G) Quantification of active caspase (Casp) 3–positive cells in 
DRGs normalized to DRG area at E15.5 reveals a decreased number of active caspase 3–positive cells in DLK
/ embryos (wt = 2.96 ± 0.24 and DLK
/ =   
1.73 ± 0.31 cells/DRG area; n = 5; **, P < 0.01). (H–M) Immunohistochemical staining with antibodies directed against the motor neuron marker HB9 
in thoracic level spinal cords of DLK
/ and wt (DLK
+/+) littermates at E13.5, 15.5, and 17.5. DLK
/ spinal cords have more HB9-positive cells than wt 
controls at E15.5 and 17.5. The edge of the spinal cord is indicated by the dotted lines. Bar, 25 µm. (N) Quantification of HB9-positive neurons reveals 
an equal number of labeled cells in DLK
/ and wt (DLK
+/+) at E13.5 but a significant increase in the number of labeled cells at E15.5 and 17.5 (E13.5 = 
94 ± 8.1%, E15.5 = 186 ± 11%, and E17.5 = 180 ± 14% of wt control [Cntl]; n = 3; ***, P < 0.001). Error bars represent SEM.761 DLK required for JNK-dependent neuronal degeneration • Sengupta Ghosh et al.
(Ito et al., 1999), raising the possibility that a significant amount 
of DLK–JIP3 signaling after NGF withdrawal could occur via 
JNK3. On the other hand, experiments in primary neurons have 
demonstrated that pan-JNK inhibition is sometimes required to 
provide complete rescue from degeneration (Björkblom et al., 
2008), arguing that other JNK genes can also contribute to this 
process. Our data demonstrate that phosphorylation of both the 
46- and 55-kD JNK bands is increased after NGF withdrawal 
and implies that multiple JNKs become activated, though it is 
possible that this pattern represents phosphorylation of different 
splice forms of a single JNK gene (Gupta et al., 1996). How-
ever, we also observed that knockout or siRNA-based knock-
down of any individual JNK gene was not sufficient to provide 
protection after NGF withdrawal (unpublished data). This sug-
gests that degeneration is likely mediated by a combination of JNK 
genes and that additional components of the pathway such as 
DLK and/or JIPs are necessary for regulation of prodegeneration- 
specific JNK activity.
c-Jun–independent functions of DLK–JNK  
in degeneration
The  c-Jun–independent  regulation  of  axon  degeneration  by 
DLK–JNK makes a strong case that phosphorylation of addi-
tional  downstream  targets  is  required  for  DLK-dependent   
neuronal  degeneration.  Several  transcription  factors  can  be 
phosphorylated  by  JNKs,  including ATF2  (Widmann  et  al., 
1999), and may contribute to the breakdown of axons. The 
DLK-dependent relocalization of p-JNK to the nucleus after 
NGF withdrawal agrees with this hypothesis. However, the ob-
servation that local axon degeneration is modulated by DLK–
JNK  suggests  a  possible  alternative  scenario  in  which  this 
process is regulated via phosphorylation of axonal JNK targets. 
A local nontranscriptional role in axons would be consistent 
with the observation that both loss of DLK and pharmacologi-
cal JNK inhibition protect from Wallerian degeneration after 
axotomy (Miller et al., 2009), in which the involvement of tran-
scription is not possible. Several cytosolic JNK targets have 
been identified in neurons that may contribute to this degenera-
tion, including doublecortin, SCG10, and Tau (Goedert et al., 
1997; Gdalyahu et al., 2004; Tararuk et al., 2006). In addition, 
evidence exists in other systems that JNK is able to phosphory-
late members of the intrinsic apoptotic machinery, including 
Bcl-2–associated  death  promoter  and  Bcl-2–like  protein  11 
(Donovan et al., 2002; Putcha et al., 2003). Phosphorylation of 
these substrates in axons may also contribute to degeneration, 
which is consistent with our finding that caspase activity in the 
axon can be modulated by DLK–JNK independent of c-Jun.
In summary, we have demonstrated that DLK is required 
for neuronal degeneration in peripherally projecting neuronal 
populations during development and is the primary MAPKKK 
upstream  of  c-Jun  activation  in  this  context.  Although  first   
described in developmental NGF withdrawal paradigms, the 
proapoptotic functions of c-Jun have since been shown to be 
conserved in neuronal injury and neurodegenerative disease.   
If DLK is required for JNK–c-Jun activation in the disease set-
ting as well, targeting this kinase may represent an attractive 
approach for therapeutic intervention.
inhibited by compounds such as CEP-1347, which results in a 
large reduction of total p-JNK levels (Maroney et al., 1998), sug-
gesting that DLK is able to selectively modulate a subset of JNK 
activity, resulting in phosphorylation of specific targets without 
detectably altering the total levels of p-JNK within neurons.
How does DLK achieve such specific regulation of JNK 
activity? Our data demonstrate that DLK and JIP3 are compo-
nents of a signaling complex, and knockdown of JIP3 displays 
an identical phenotype to loss of DLK in NGF-deprived neu-
rons, implying that signaling specificity may be mediated by 
this interaction. It has been hypothesized that the binding of 
specific combinations of MAPKs to scaffolding proteins can 
generate diverse signaling complexes with distinct sets of down-
stream targets (Waetzig and Herdegen, 2005), though few ex-
amples of such complexes exist for which a specialized function 
has been identified. We propose that DLK–JIP3–JNK is an ex-
ample of such a complex, which is able to selectively regulate 
stress-induced JNK activity in the context of NGF deprivation 
(Fig. 8). The observation that JIP1 does not provide similar neu-
ronal protection provides additional rationale that this is a spe-
cific function of DLK bound to JIP3. Redistribution of p-JNK 
observed after NGF withdrawal likely also plays an important 
role in degeneration and may be required to position p-JNK 
proximal to substrates such as c-Jun. Indeed, nuclear localiza-
tion of JNK has been shown to be required for neuronal apopto-
sis (Björkblom et al., 2008), and a similar relocalization has 
been observed in the context of axonal injury (Middlemas et al., 
2003). We show that both DLK and JIP3 are required for p-JNK 
relocalization in response to NGF withdrawal, arguing that it 
too is dependent on the DLK–JIP3 signaling complex. This is 
consistent with previous results that demonstrated that JIP3 can 
mediate  retrograde  transport  of  JNK  in  response  to  axonal   
injury through interactions with the P150-glued subunit of the 
dynein motor protein complex (Cavalli et al., 2005), and it is 
conceivable that DLK–JNK interaction with JIP3 mediates ret-
rograde transport of JNK after NGF withdrawal as well.
It  is  also  possible  that  the  signaling  specificity  down-
stream of DLK is mediated by activation of only a subset of the 
three JNK genes in mouse, all of which are expressed in embry-
onic neurons. The phenotypes observed in JNK-null mice   
argue that JNK2 and JNK3 are largely responsible for the JNK- 
mediated neuronal degeneration, at least in the context of injury   
(Bogoyevitch,  2006).  Furthermore,  JIP3  has  been  shown  to 
preferentially  interact  with  JNK3  over  other  JNK  isoforms   
Figure 8.  A model for the regulation of developmental apoptosis and 
axon degeneration by DLK. A complex containing DLK, JIP3, JNK, and pos-
sibly additional proteins (shown as protein X) is activated in the distal axon 
after NGF withdrawal and results in caspase-dependent neuronal apopto-
sis and axonal degeneration. Apoptosis occurs via retrograde transport 
of JNK and phosphorylation (P) of c-Jun, but axon degeneration does not 
require c-Jun and is mediated by distinct JNK targets.JCB • VOLUME 194 • NUMBER 5 • 2011   762
using  recombinant  protein  consisting  of  DLK  A597-P888;  provided  by   
S. Hirai [Yokohama City University, Japan] or Genentech; Hirai et al., 
2005). Slides were washed three times in PBS, incubated for 1 h at room 
temperature with Alexa Fluor–conjugated secondary antibodies (Invitro-
gen) followed by 3× PBS washes, and mounted in Fluoromount-G. Staining 
of tissue was performed using the protocol above but with PBS containing 
5% normal goat serum and 0.1% Triton X-100 on 20-µm transverse sec-
tions cut on a cryostat. The antibodies used were pan-Trk (Cell Signaling 
Technology), activated caspase 3 (R&D Systems), HB9 (a gift from S. Pfaff), 
and Alexa Fluor–conjugated secondary antibodies (Invitrogen). For whole-
mount embryo neurofilament staining, embryos were eviscerated, fixed in 
4% PFA, and stained with rabbit anti-Neurofilament antibody (Covance) 
using the same protocol as described above, except that all antibody incub-
ations were overnight, and buffers included 0.4% Triton X-100.
Western blotting and IP
DRG cultures were lysed in 100 µl Triton X-100 lysis buffer (20 mM Tris, 
pH 7.5, 150 mM NaCl, 0.1% Triton X-100, and protease and phospha-
tase inhibitors) for 30 min at 4°C. Because of the limited amount of protein 
harvested from DRGs, protein was precipitated using TCA and then washed 
with acetone three times to remove the residual TCA. The pellet was dried 
and resuspended in 1× SDS NuPAGE loading buffer containing a reduc-
ing agent. The amount of protein in samples was quantified by Western 
blotting for tubulin. Similar amounts of protein were then loaded on 4–12% 
Bis-Tris gels and subjected to standard immunoblotting procedures. Primary 
antibodies used for Western blotting were the same as those used for   
immunocytochemistry. Blot images were taken and quantified using the 
VersaDoc system (Bio-Rad Laboratories). p-JNK (upper band) and p-ERK 
(lower band) were quantified by normalizing to total levels of JNK and 
ERK,  respectively,  and  were  then  compared  with  wt  control  or  control 
siRNA with NGF. p-c-Jun quantification was also normalized to wt/control 
siRNA with NGF present. Each experiment for Western blots on DLK
/ 
neurons was performed with more than or equal to three embryos for each 
condition and repeated three times, whereas siRNA knockdown Western 
blots used electroporated DRG neurons from five embryos for each condi-
tion and were repeated more than or equal to two times. The p-JNK and   
p-c-Jun time course blots were performed with more than or equal to two 
embryos for each genotype at each time point.
IP studies in HEK-293 cells used a full-length mouse coding sequence 
of N-terminal Flag-tagged DLK, N-terminal Myc-tagged JIP3, and GFP ex-
pressed using Fugene6. 20 h after transfection, cells were washed with 
cold PBS and were lysed in 100 µl Triton X-100 lysis buffer (see above) for 
30 min at 4°C. The amount of protein was quantified using bicinchoninic 
acid protein assay reagent (Thermo Fisher Scientific), and 200 µg of pro-
tein was taken for IP using a Flag IP kit (Sigma-Aldrich). 5% of protein was 
run as input, whereas 30% of the IP was run on Western blots. The IP ex-
periment was repeated three times and showed similar results. For IP from 
mouse brain, whole brain was harvested from postnatal day 1 mice and 
lysed in buffer containing 1% Triton X-100, 150 mM NaCl, 50 mM Tris/
HCl, and 1mM EDTA for 30 min at 4°C. IP was conducted using protein A–
Sepharose beads and a DLK antibody (Genentech) or a rabbit IgG anti-
body. Beads were then washed twice in the lysis buffer followed by two 
washes in buffer without Triton X-100, and protein was then eluted in 1× 
SDS loading buffer containing a reducing agent. Equal amounts of brain 
lysate were added to each IP condition. Approximately 2% of the protein 
was run as input, whereas 30% of the pull-down was run in each lane   
of the Western blots and blotted with DLK (Genentech) or JIP3 (Novus Bio-
logicals) antibody.
Imaging and quantification
Images of cultured neurons were acquired using a fluorescent micros-
cope (DM5500; Leica) with a camera (DFC360) using a 20 or 40× objective, 
whereas whole-mount embryos and Trk-positive DRGs were imaged on a 
confocal microscope (LSM710; Carl Zeiss) using a 10 or 20× objective, 
respectively. Whole mounts were imaged as a flattened z stack and pre-
sented as maximum intensity projections.  was altered to weak signal   
in compartmentalized chamber images shown in Fig. 5 and to more easily 
visualize neuritis in Figs. 6 (K and M) and S3 C using Photoshop (Adobe), 
but all data within a panel were identically imaged and modified. For all 
quantifications, values represent the mean of multiple experiments, and   
error bars represent SEM.
Axon degeneration in DRG explants and compartmentalized cul-
tures was quantified blindly on a scale of 0–5, in which 0 equals no degen-
eration  (equivalent  to  control  cultures  containing  NGF)  and  5  equals 
complete degeneration. Representative images were used to define inter-
mediate stages of degeneration. For explant experiments, n = 5 embryos 
Materials and methods
Mouse models
DLK knockout mice were generated by homologous recombination using   
a phosphoglycerate kinase–neomycin cassette flanked by homology arms 
of 5.1 and 2.8 kb. The 5 arm contained a LoxP site 1.5 kb away from   
the neomycin cassette. Embryonic stem (ES) cells were screened via PCR 
with the following primers, which amplified over both homology arms:   
5-AGGGGATAGTACAGCTCTGTGG-3, 5-CTGCGTGCAATCCATCTTG-3 
(5 arm), 5-CTTGTCGATCAGGATGATCTGG-3, and 5-CTACTGTCAT-
CAAAGCTGCCAC-3 (3 arm). The primers were confirmed via Southern 
blotting. Transfection of ES cells with a Cre-expressing plasmid resulted in 
recombination, which was assessed with the following primes: 5-CACATC-
CTAGCCAAGTGCTCTAC-3, 5-ATCTGCCTTGTGTACCTGGGA-3, and 
5-CTTGGGGACTAAGGTCAGTGAC-3.  HB9:GFP  mice  were  obtained 
from S. Pfaff (Salk Institute, La Jolla, CA) and have been previously de-
scribed (Lee et al., 2004). c-Jun knockout mice were obtained from E. Wagner 
(Centro Nacional de Investigaciones Oncológicas, Madrid, Spain), have 
been previously described (Behrens et al., 2002), and were crossed to 
Nestin-Cre (Jackson ImmunoResearch Laboratories, Inc.) to eliminate c-Jun 
expression in neurons.
Primary neuron culture
E13.5 DRGs were dissected and cultured in F12 media containing N3 
supplement, glucose, and 25 ng/ml NGF on precoated poly-d-lysine and 
laminin chamber slides (BioCoat; BD). In DRG explant experiments 24 h 
after plating, media were replaced with media containing no NGF and   
25 µg/ml anti-NGF antibody (Genentech) for various time periods and 
were then fixed for staining. For dissociated cultures, DRGs were digested 
in 0.05% trypsin for 30 min at 37°C and were plated as described above. 
24 h after plating, mitotic inhibitor (cytosine arabinofuranoside [AraC]) 
was added to the culture and then removed 24 h later. NGF was with-
drawn from the culture 4–5 d after plating as described above. In experi-
ments using JNK inhibitor AS601245 (also known as JNK inhibitor V; 
EMD), 10 mM stock solution was made in DMSO and diluted to 10 µM 
working  concentration  in  media.  Compartmentalized  chamber  assays 
were  performed  essentially  as  previously  described  (Nikolaev  et  al., 
2009). In brief, 35-mm tissue culture dishes were coated with poly-d-lysine 
and laminin and scratched with a pin rake (Tyler Research) to generate 
tracks for axonal growth. 50 ml of culture media containing 4 mg/ml 
methylcellulose was placed on the scratched area so that axons could 
grow within the tracks. A Teflon divider (Camp8; Tyler Research) that cre-
ates a central cell body chamber flanked by two axon chambers was then 
seated on silicone grease and placed on the culture dish as such that the 
cell body chamber was in the middle of the scratched area. Dissociated DRGs 
from E13.5 mouse embryos were suspended in methylcellulose-thickened 
medium and loaded in the cell body compartment, and both axon compart-
ments were filled with culture media with 4 mg/ml methylcellulose. 1 d after 
plating, media containing 7 mM AraC were added to the cell body   
compartment for a period of 24 h. 3–5 d after plating, NGF was withdrawn 
from different compartments by replacing media containing 4 mg/ml methyl-
cellulose and 25 mg/ml anti-NGF antibody.
For  siRNA  experiments,  dissociated  DRGs  were  transfected  with 
siRNA using a nucleofection system (Lonza). DLK siRNA (sense 5-GCACT-
GAATTGGACAACTCTT-3  and  antisense  5-GAGTTGTCCAATTCAGT-
GCTT-3) was synthesized at Genentech, and JIP1 (sc-35723; Santa Cruz 
Biotechnology, Inc.) and two siRNAs targeted to different regions of JIP3 
(SI01300789  and  SI01300796;  QIAGEN)  were  purchased.  Levels  of 
knockdown were tested by quantitative PCR at 5 d after plating using the 
Syber green qPCR kit (QIAGEN) and verified primer sets (QIAGEN) for 
JIP1, JIP3, and DLK. The control siRNA used was an siRNA directed against 
luciferase. Glyceraldehyde 3-phosphate dehydrogenase expression level 
was used as a control for all samples. Quantitative PCR was analyzed by 
the –CT method comparing expression levels to the level of expres-
sion in control siRNA. Quantitative PCR was performed in triplicate (n ≥ 2   
experiments for each siRNA).
Immunocytochemistry and immunohistochemistry
Cultured neurons were fixed with 4% PFA and 15% sucrose for 30 min at 
room temperature, were blocked and permeabilized in PBS with 5% BSA 
and 0.2% Triton X-100 for 1 h, and were then stained overnight in block-
ing buffer, which contained the following antibodies: p-JNK, p-c-Jun serine 
63 total JNK, ERK, p-ERK, cleaved caspase 3, cleaved caspase 9 (Cell Sig-
naling Technology), Neuronal Class III -tubulin (TuJ-1; Covance), NuN 
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with more than three explants scored per embryo. For compartmentalized 
chamber experiments, more than four chambers were quantified in two in-
dependent experiments. Axon degeneration quantification in dissociated 
DRG  neurons  was  conducted  using  MetaMorph  software  (Molecular   
Devices). A journal that quantifies intact axons only was written and used 
to quantify all images, giving a total neurite length as a final readout for 
each image. Total neurite length in each condition was normalized to total 
neurite length in control wells containing NGF. More than or equal to three 
representative images from each experiment were quantified, and the data 
presented are representative of three independent experiments.
Quantifications of caspase 3 staining in dissociated DRG neurons 
were conducted manually by counting individual caspase 3/Tuj1-positive 
cell bodies. Three to five fields of each condition were quantified, and data 
are representative of at least two independent experiments. Caspase 9 
staining in DRG axons was quantified using a relative scale of 0–5, in 
which 0 indicates that no axons are stained, and 5 indicates that all axons 
are stained. n = 3 embryos for each genotype with more than three ex-
plants scored per embryo.
p-c-Jun staining in compartmentalized chambers was quantified by 
blindly counting number of p-c-Jun–stained cells and normalizing to the 
number of DAPI-positive cells. Four regions from two independent experi-
ments were quantified. p-JNK relocalization within neurons was quantified 
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Mean pixel intensity was then multiplied by area to generate a total pixel 
intensity for each region. The total pixel intensity associated with NeuN 
was then divided by the total pixel intensity of the image. Four regions from 
two independent experiments were quantified.
In vivo cell counts were quantified by counting the number of Trk-
positive cells on each section and were normalized to DRG area on each 
section using ImageJ (National Institutes of Health). At least 8–10 sections 
were quantified per embryo, with n = 3 embryos per genotype. Quantifica-
tion of activated caspase 3 was conducted using the same method (n = 5 
embryos per genotype; a total of ≤25 DRG sections was quantified per 
genotype). For HB9 staining, numbers of positive neurons/motor column 
were manually counted in 8–10 lower lumbar sections per embryo, with   
n = 3 embryos quantified from each developmental stage and genotype. 
All counts were performed blind to genotype.
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DLK
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